CHI3L1 and neoplasm: It would be interesting to further address the role of YKL-40 on the peritumor immune microenvironment and ASC response to treatment, especially by evaluating the spatial and longitudinal changes of YKL-40 immune cell protein expression in post-treatment tumor samples.